ABCureD is a biomedical R&D start-up focusing on biomarker and drug target discovery.
Our aim is to improve the quality of clinical decisions and accelerate biomedical research to bring real solutions for peoples’ health.
We apply data and biology-driven approaches to produce highly performing biosignatures specific for clinically significant disease end-points, in multiple diseases including cancer and diabetes. We employ innovative automated machine learning and text data mining bioinformatic tools to optimise and accelerate discovery. We then validate models in patient cohorts, focusing on liquid biopsies, to offer mature blood-based solutions readily available for minimally invasive diagnostics anticipated to disrupt clinical management. Novel data-driven drug targets are also identified.
The team lead, Ekaterini Alexiou Chatzaki (PhD), is a Professor and Director of the laboratory of Pharmacology at DUTH and Director of the Institute of Agri-Health, Hellenic Mediterranean University Research Centre, Crete, Greece. She’s been leading the team since 2002, with special interests in Epigenetic/ Pharmacoepigenetics. The team currently consists of 5 post-docs and numerous PhD and post-graduate Biologists.